I have trouble understanding why AGS should pay a toll, when they have contributed 25% to all development costs. Is this extortion? Or stupidity?
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling